Download
art:10.1186/1756-8935-4-16.pdf 3,65MB
WeightNameValue
1000 Titel
  • Chromatin regulated interchange between polycomb repressive complex 2 (PRC2)-Ezh2 and PRC2-Ezh1 complexes controls myogenin activation in skeletal muscle cells
1000 Autor/in
  1. Stojic, Lovorka |
  2. Jasencakova, Zuzana |
  3. Prezioso, Carolina |
  4. Stützer, Alexandra |
  5. Bodega, Beatrice |
  6. Pasini, Diego |
  7. Klingberg, Rebecca |
  8. Mozzetta, Chiara |
  9. Margueron, Raphael |
  10. Puri, Pier Lorenzo |
  11. Schwarzer, Dirk |
  12. Helin, Kristian |
  13. Fischle, Wolfgang |
  14. Orlando, Valerio |
1000 Erscheinungsjahr 2011
1000 LeibnizOpen
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2011-09-05
1000 Erschienen in
1000 Quellenangabe
  • 4: 16
1000 FRL-Sammlung
1000 Copyrightjahr
  • 2012
1000 Lizenz
1000 Verlagsversion
  • http://doi.org/10.1186/1756-8935-4-16 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180244/ |
1000 Ergänzendes Material
  • https://epigeneticsandchromatin.biomedcentral.com/articles/10.1186/1756-8935-4-16#Declarations |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • BACKGROUND: Polycomb group (PcG) genes code for chromatin multiprotein complexes that are responsible for maintaining gene silencing of transcriptional programs during differentiation and in adult tissues. Despite the large amount of information on PcG function during development and cell identity homeostasis, little is known regarding the dynamics of PcG complexes and their role during terminal differentiation. RESULTS: We show that two distinct polycomb repressive complex (PRC)2 complexes contribute to skeletal muscle cell differentiation: the PRC2-Ezh2 complex, which is bound to the myogenin (MyoG) promoter and muscle creatine kinase (mCK) enhancer in proliferating myoblasts, and the PRC2-Ezh1 complex, which replaces PRC2-Ezh2 on MyoG promoter in post-mitotic myotubes. Interestingly, the opposing dynamics of PRC2-Ezh2 and PRC2-Ezh1 at these muscle regulatory regions is differentially regulated at the chromatin level by Msk1 dependent methyl/phospho switch mechanism involving phosphorylation of serine 28 of the H3 histone (H3S28ph). While Msk1/H3S28ph is critical for the displacement of the PRC2-Ezh2 complex, this pathway does not influence the binding of PRC2-Ezh1 on the chromatin. Importantly, depletion of Ezh1 impairs muscle differentiation and the chromatin recruitment of MyoD to the MyoG promoter in differentiating myotubes. We propose that PRC2-Ezh1 is necessary for controlling the proper timing of MyoG transcriptional activation and thus, in contrast to PRC2-Ezh2, is required for myogenic differentiation. CONCLUSIONS: Our data reveal another important layer of epigenetic control orchestrating skeletal muscle cell terminal differentiation, and introduce a novel function of the PRC2-Ezh1 complex in promoter setting.
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/creator/U3RvamljLCBMb3Zvcmth|https://frl.publisso.de/adhoc/creator/SmFzZW5jYWtvdmEsIFp1emFuYQ==|https://frl.publisso.de/adhoc/creator/UHJlemlvc28sIENhcm9saW5h|https://frl.publisso.de/adhoc/creator/U3TDvHR6ZXIsIEFsZXhhbmRyYQ==|https://frl.publisso.de/adhoc/creator/Qm9kZWdhLCBCZWF0cmljZQ==|https://frl.publisso.de/adhoc/creator/UGFzaW5pLCBEaWVnbw==|https://frl.publisso.de/adhoc/creator/S2xpbmdiZXJnLCBSZWJlY2Nh|https://frl.publisso.de/adhoc/creator/TW96emV0dGEsIENoaWFyYQ==|https://frl.publisso.de/adhoc/creator/TWFyZ3Vlcm9uLCBSYXBoYWVs|https://frl.publisso.de/adhoc/creator/UHVyaSwgUGllcsKgTG9yZW56bw==|http://orcid.org/0000-0002-7477-3319|https://frl.publisso.de/adhoc/creator/SGVsaW4sIEtyaXN0aWFu|https://frl.publisso.de/adhoc/creator/RmlzY2hsZSwgV29sZmdhbmc=|https://frl.publisso.de/adhoc/creator/T3JsYW5kbywgVmFsZXJpbw==
1000 Label
1000 Förderer
  1. Deutsche Forschungsgemeineschft (DFG) |
  2. Danish National Research Foundation |
  3. Max Planck Society |
  4. Telethon |
  5. AIRC (Associazione Italiana Ricerca sul Cancro) |
  6. Epigenome NoE |
  7. EMBO |
  8. Danish Medical Research Council |
1000 Fördernummer
  1. SCHW 1163/3-1
  2. -
  3. -
  4. S00094
  5. -
  6. -
  7. -
  8. -
1000 Förderprogramm
  1. Emmy-Noether program
  2. -
  3. -
  4. -
  5. -
  6. FP6
  7. Human Frontier Science Program (HFSP) fellowship
  8. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Deutsche Forschungsgemeineschft (DFG) |
    1000 Förderprogramm Emmy-Noether program
    1000 Fördernummer SCHW 1163/3-1
  2. 1000 joinedFunding-child
    1000 Förderer Danish National Research Foundation |
    1000 Förderprogramm -
    1000 Fördernummer -
  3. 1000 joinedFunding-child
    1000 Förderer Max Planck Society |
    1000 Förderprogramm -
    1000 Fördernummer -
  4. 1000 joinedFunding-child
    1000 Förderer Telethon |
    1000 Förderprogramm -
    1000 Fördernummer S00094
  5. 1000 joinedFunding-child
    1000 Förderer AIRC (Associazione Italiana Ricerca sul Cancro) |
    1000 Förderprogramm -
    1000 Fördernummer -
  6. 1000 joinedFunding-child
    1000 Förderer Epigenome NoE |
    1000 Förderprogramm FP6
    1000 Fördernummer -
  7. 1000 joinedFunding-child
    1000 Förderer EMBO |
    1000 Förderprogramm Human Frontier Science Program (HFSP) fellowship
    1000 Fördernummer -
  8. 1000 joinedFunding-child
    1000 Förderer Danish Medical Research Council |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6403083.rdf
1000 Erstellt am 2017-06-16T09:10:40.141+0200
1000 Erstellt von 25
1000 beschreibt frl:6403083
1000 Bearbeitet von 288
1000 Zuletzt bearbeitet Thu Aug 18 07:59:13 CEST 2022
1000 Objekt bearb. Wed Mar 31 07:29:57 CEST 2021
1000 Vgl. frl:6403083
1000 Oai Id
  1. oai:frl.publisso.de:frl:6403083 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source